期刊文献+

可溶性CD40配体对THP-1细胞增殖及survivin mRNA表达的影响

Effect of Soluble CD40 Ligand on Proliferation of THP-1 Cells and Expression of survivin mRNA
下载PDF
导出
摘要 目的:研究可溶性CD40配体(Soluble CD40Ligand,sCD40L)对人白血病THP-1细胞增殖的作用,并探讨其对生存素mRNA(survivin mRNA)及白细胞介素6(IL-6)表达的影响。方法:采用MTT法检测sCD40L孵育THP-1细胞体外增殖的影响;通过RT-PCR检测survivin mRNA表达;ELISA测定IL-6的影响。结果:不同浓度的sCD40L对THP-1细胞增殖有抑制作用,并呈剂量-时间依赖关系;sCD40L对THP-1细胞survivin及IL-6的表达有明显的抑制作用,并呈剂量-时间依赖性。结论:sCD40L在体外能够明显抑制THP-1细胞增殖,具有剂量-时间依赖性。sCD40L抑制THP-1细胞增殖与survivin及IL-6表达相关,并可能与其下调有关。 Objective:To investigate the effect of sCD40 Lon proliferation of THP-1cells and expressions of IL-6and survivin.Methods:The MTT assay was used to examine the effect of different concentrations of sCD40 Lon Leukemia THP-1cells proliferation in vitro at different incubation times;RT-PCR was used to determine the effect of different concentrations of sCD40 Lon the expression of survivin mRNA in THP-1cells at different incubation times;ELISA was used to detect changes in cytokine IL-6levels in the culture supernatants of leukemia THP-1cells of different concentrations of sCD40 Lat different incubation times.Results:Different concentrations of sCD40 Lcould all significantly inhibit THP-1cells proliferation and there was a dose-dependent tendency.sCD40 Lcould suppress the expression of survivin and IL-6,and with dose-dependent manner.Conclusion:sCD40Lcan significantly inhibit the proliferation of THP-1cells in vitro,yet it is concentration and time dependent;the mechanisms of sCD40 Lin inhibiting the proliferation of THP-1cells and inducing apoptosis in THP-1cells may be related to their inhibition of IL-6and survivin expression.
出处 《医学理论与实践》 2015年第14期1852-1854,1873,共4页 The Journal of Medical Theory and Practice
基金 贵州省社会发展攻关项目(黔科合SY字[2014]3025号) 贵州省科技厅联合基金(黔科合J字LKZ[2013]55号)
关键词 可溶性CD40配体 THP-1 细胞增殖 SURVIVIN 白细胞介素6 sCD40L THP-1 Cell proliferation survivin IL-6
  • 相关文献

参考文献9

  • 1Hai-Qing Huang,Xiang-Zhong Fang,Jun Shi,Jie Hu.Abnormal localization of immature precursors (ALIP) detection for early prediction of acute myelocytic leukemia (AML) relapse[J]. Medical & Biological Engineering & Computing . 2014 (2)
  • 2Rotem Kedar,Ofra Sabag,Michal Licthenstein,Haya Lorberboum‐Galski.Soluble CD40 ligand (sCD40L) provides a new delivery system for targeted treatment[J]. Cancer . 2012 (24)
  • 3Jagat R. Kanwar,Sishir K. Kamalapuram,Rupinder K. Kanwar.Targeting survivin in cancer: the cell-signalling perspective[J]. Drug Discovery Today . 2011 (11)
  • 4Angelica S.I. Loskog,Aristides G. Eliopoulos.The Janus faces of CD40 in cancer[J]. Seminars in Immunology . 2009 (5)
  • 5Li Rui,Chen Wei-Chang,Pang Xue-Qin,Tian Wen-Yan,Zhang Xue-Guang.Influence of sCD40L on gastric cancer cell lines. Molecular Biology . 2011
  • 6Law Che-Leung,Grewal Iqbal S.Therapeutic interventions targeting CD40L (CD154) and CD40: the opportunities and challenges. Advances in experimental medicine and biology . 2009
  • 7Aldinucci Donatella,Cattaruzza Lara,Lorenzon Debora,Giovagnini Lorena,Fregona Dolores,Colombatti Alfonso.Antiproliferative and apoptotic effects of two new Pd(11) methylsarcosinedithiocarbamate derivatives on human acute myeloid leukemia cells in vitro. Oncology Research . 2008
  • 8Ghasemi A,Rostami S,Chahardouli B,et al.Study of SFRP1and SFRP2methylation status in patients with de novo Acute Myeloblastic Leukemia. Int J Hematol Oncol Stem Cell Res . 2015
  • 9Ibrahim Bayram.Hematopoietic Stem Cell Transplantation in Children with Acute Myeloblastic Leukemia. Arsiv Kaynak Tarama Dergisi . 2014

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部